PerkinElmer Introduces Enhanced Software and Live Cell Imaging Capabilities for Opera® High Content Screening System
Global leader in cellular imaging and analysis unveils new software and hardware features for improved life science and drug discovery research productivity
The enhancements to the Opera system will enable biopharmaceutical and academic researchers to perform improved live cell imaging assays, for more efficient drug discovery and life science research workflow.
The new features increase ease of use of the Opera system's Acapella®
High Content Imaging and
The Opera system's new transmitted light module with digital phase-contrast will enable users to image and segment cells that have not been labeled fluorescently. This feature is especially useful for live cell applications as it eliminates the need to label cells, thus diminishing potential labeling artifacts, cell damage, assay costs and time.
"We understand the importance of making our high performance systems
even easier to use in order to continue to improve our customers'
research workflow," said
PerkinElmer's PhenoLOGIC™ machine-learning technology is now available for the Acapella software, and will enable Acapella software users to classify different cell populations or regions by simple point-and-click operations. In addition, a new 4X objective lens will enable users to quickly scan entire wells from which they can choose an area to examine in more detail.
About PerkinElmer, Inc.
PerkinElmer, Inc. is a global leader focused on improving the health and
safety of people and the environment. The Company reported revenue of
Source: PerkinElmer, Inc.
News Provided by Acquire Media